Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model by Laure B. Bindels (155478)

Α-Difluoromethylornithine (DFMO) decreases the incidence and size of bone metastases from MDA-MB-435 cells by Monica M Richert (63671)

“…<p><b>Copyright information:</b></p><p>Taken from "Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment"</p><p>Breast Cancer Research 2005;7(5):R819-R827.…”

GLP-1 decreased ROS generation, migration, and MMPs activity in monocytic cells by Ang II stimulation. by Hsin Ying Lu (723263)

Aliskiren decreases toxicity induced by peritoneal dialysis fluids (PDFs) in rat peritoneal mesothelial cells (PMCs). by Juan Pérez-Martínez (324784)

Silencing of Rac1 and IQGAP1 decreases HPAEC migration in an <i>in vitro</i> scratch assay. by Evgeny V. Berdyshev (307465)

Early decreased neutrophil responsiveness is related to late onset sepsis in multitrauma patients: An international cohort study by Kathelijne M. Groeneveld (4217515)

“…Decreased neutrophil responsiveness appears to be a prerequisite for septic shock after trauma. …”

Hierarchial clustering and VENN-diagram of identified proteins. by Piia Karisola (266792)

“…Two main clusters are found; one consisting of 12 α-GalCer-treated WT samples, the other containing 8 α-GalCer-treated Jα18-KO and CD1d-KO mice samples and 4 vehicle-treated WT samples, which all look alike. …”

GF mice transplanted with fecal microbiota from colitis mice displayed decreased levels of SCFAs and their receptors. by Chungho Lee (8431335)

Injection of dGAG-KI01 Decreases P. falciparum Sequestration of IE of Clinical Isolates in the Rat by Anna M Vogt (21629)

Transfection of siRNA against β-catenin into HSlo-HEK cells decreases surface expression of HSlo. by Shumin Bian (191969)

“…Compared to cells transfected with either no DNA (A), or with siRNA against the chick β4 subunit of Slo that has no comparable sequence identity in mammals (B), cells transfected with siRNA against β-catenin have decreased surface labeling (C). As expected, transfection of siRNA against HSlo eliminates nearly all surface HSlo signal (D). …”

Predicted lowest-free energy structures of the region surrounding the AUG start codon (blue box) in wild-type and in mutant <i>proA*</i> transcripts in which synonymous mutations i... by JohnCarlo Kristofich (5687573)

Effects of heat shocks on whole grain dimensions. by Christine Girousse (5447276)

Demonstration of NiV-induced lesion in the brain of AGM. by Dima A. Hammoud (619616)

“…<p>Magnetic resonance imaging (MRI) was performed prior to and at multiple time points following NiV-exposure. (A) MRI scans from animal #8150 obtained at day 10 PI. …”

The RNA helicase DDX3X is an essential mediator of innate antimicrobial immunity by Daniel Szappanos (6009746)

“…<div><p>DExD/H box RNA helicases, such as the RIG-I-like receptors (RLR), are important components of the innate immune system. …”

Loss of Vps34 reduces Treg suppressive function and is associated with the development of type-I-dominant inflammatory disease. by Erienne G. Norton (9612079)

Ivermectin significantly decreases <i>L</i>. <i>loa</i> mf in BALB/c mice. by Rene Bilingwe Ayiseh (6900296)

Production of intracellular reactive oxygen species (ROS) in hESCs was decreased after NaF treatment. by Xin Fu (448766)

“…<p>(A) Assessment of ROS levels by 2,7-dichlorodihydrofluorescein-diacetate (DCFH-DA) staining revealed that the percentage of fluorescent dichlorofluorescein (DCF)-positive hESCs was significantly decreased in the 2 and 4 mM NaF-treated groups, and the mean fluorescence intensities of hESCs were significantly lower in the 1, 2 and 4 mM NaF-treated groups. …”

Decreased neuronal differentiation of NSPCs by soluble mediators from JEV activated microglia is reversed by minocycline treatment. by Sulagna Das (228386)

Down-regulation of GPER reverses the decreased expression of PCNA and cell morphology changes caused by G-1. by Fen Li (337013)

Occupancy of Sp1 at GC1 of the topoisomerase IIα promoter decreases after doxorubicin treatment by Amram O Williams (31067)